Only 25 of approximately 250 actively traded cannabis stocks fulfill the criteria for inclusion in the equal-weighted munKNEE Pure-Play Pot Stock Portfolio. Only 2 participants’ stock prices were higher in September – Jushi and Ayr Strategies. [more]
Lift & Co is the latest company to seek creditor protection and all of its directors and officers have resigned. This follows the failure to reach an agreement with the holders of the Corporation’s secured convertible debentures. [more]
The cannabis stock universe has over 400 securities listed on the various Canadian and American stock exchanges of which approximately 300 are actively trade. The 10 featured cannabis companies are higher on average 57.2% over the past 8 months. [more]
This past quarter, Canadian cannabis companies focused on consolidating operations, adjusting asset valuations, and launching Cannabis 2.0 derivative products. While in the U.S., cannabis companies increased production capacity and scaled retail stores in order to be ready when federal legalization of cannabis becomes a reality. [more]
Cannabis stock prices continue to be under pressure as the overall market struggles to find footing amid the coronavirus crisis with numerous companies announcing impairments, write-downs, deal adjustments, and financings. However, some companies continue to execute partnerships and launch new retail stores. [more]
Only 6 pure-play, non-penny cannabis stocks are higher year-to-date out of a total of 300 actively traded cannabis stocks listed on the various North American stock exchanges. The 6 stocks are up 7.4% YTD on average. [more]
Seven major consumer and pharmaceutical corporations have bought into cannabis companies to take full advantage of this rapidly growing market. This article compares their YTD stock performance with that of their cannabis partner. [more]
298 cannabis stocks trade on N.A. stock exchanges and are down 25.9% YTD. Lorimer Wilson from MunKNEE.com highlights the performance of the 12 “momentum” stocks within the Non-penny Pot Stock Index that are all up this year. [more]
Since Canada approved the sale of cannabis derivatives late last year, the high-margin cannabis beverage market quickly grew with the introduction of new products and brands, and an increase in M&A, financings, and other deals. [more]
Recently, the psychedelic market garnered the attention of investors as the industry was catalyzed by IPOs from MindMed Medicine and Champignon Brands with both companies quickly reaching market caps of over $100M due to significant demand in this new space. [more]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes